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Birth defectsmay inﬂuence the risk of childhood cancer development through a variety of mechanisms. The rarity
of both birth defects and childhood cancers makes it challenging to study these associations, particularly for the
very rare instances of each. To address this limitation, the authors conducted a record linkage-based cohort study
among Texas children born between 1996 and 2005. Birth defects in the cohort were identiﬁed through the Texas
Birth Defects Registry, and children who developed cancer were identiﬁed by using record linkage with Texas
Cancer Registry data. Over 3 million birth records were included; 115,686 subjects had birth defects, and there
were 2,351 cancer cases. Overall, children with a birth defect had a 3-fold increased risk of developing cancer
(incidence rate ratio (IRR) ¼ 3.05, 95% conﬁdence interval (CI): 2.65, 3.50), with germ cell tumors (IRR ¼ 5.19,
95% CI: 2.67, 9.41), retinoblastomas (IRR ¼ 2.34, 95% CI: 1.21, 4.16), soft-tissue sarcomas (IRR ¼ 2.12, 95% CI:
1.09, 3.79), and leukemias (IRR ¼ 1.39, 95% CI: 1.09, 1.75) having statistically signiﬁcant elevated point estimates.
All birth defect groups except for musculoskeletal had increased cancer incidence. Untangling the strong relation
between birth defects and childhood cancers could lead to a better understanding of the genetic and environmental
factors that affect both conditions.
birth defects; childhood cancers; congenital anomalies
Abbreviations: CDC, Centers for Disease Control and Prevention; CI, conﬁdence interval; ICCC-3, International Classiﬁcation of
Childhood Cancer, Third Edition; IRR, incidence rate ratio.
Studies have consistently shown that children born with
certain types of birth defects are at increased risk of devel-
oping cancer during childhood (1–7). There are a variety of
ways by which the presence of birth defects may inﬂuence
risk of childhood cancer development, including through
sharedgenetic and/or environmental factors,through changes
in organ structure or function, or through lifestyle adaptations
related to the malformation. Established birth defect-childhood
cancer associations include Down syndrome and speciﬁc
leukemias, autosomal deletion of 13q14 and retinoblastoma,
and Beckwith-Weideman syndrome and Wilms’ tumor (8).
The magnitude of the association can be quite strong, with
studies reporting that Down syndrome children have a 10–
50-fold increased risk of developing acute lymphoblastic
leukemia or acute myeloid leukemia compared with non-
Down syndrome children (9).
In addition to genetic factors, there are indications that
environmental exposures may mediate risk of cancer among
children with birth defects. In Down syndrome children,
some factors have been found to be protective against leuke-
mias(e.g., maternal vitamin use (10)), while others appear
to increase risk (e.g., maternal exposure to pesticides (11),
maternal infertility (12)). An intriguing aspect of Down
syndrome cancer risk is the ﬁnding that Down syndrome
children and adults actually have a lower incidence of solid
tumors than the non-Down syndrome population (13).
The reports of increased risk of childhood cancers among
children with birth defects may be an indication that these
children constitute a high-risk population. As such, study of
this population could help to improve our understanding of
certain etiologies of childhood cancers and to identify the
genetic and environmental factors driving carcinogenesis in
children in the general population. The rarity of both birth
defects and childhood cancers makes it challenging, how-
ever, to study the association between meaningful groups of
birth defects and speciﬁc cancers, particularly for the very






























































































 rare instances of each. To mitigate this limitation, we con-
ducted a record linkage-based cohort study among children
born over a 10-year period in Texas, the second most pop-
ulous state in the United States. With more than 400,000
births currently recorded annually in Texas, this birth cohort
was deemed likely to provide sufﬁcient numbers to allow for
evaluation of the association of speciﬁc birth defects with
speciﬁc childhood cancers.
MATERIALS AND METHODS
The birth cohort identiﬁed for the study consisted of chil-
dren born to Texas residents between January 1, 1996, and
December 31, 2005 (n ¼ 3,186,911 livebirths). Birth certif-
icate data ﬁles for the cohort were provided by the Vital
Statistics Unit/Center for Health Statistics of the Texas
Department of State Health Services.
Children with and without identiﬁed birth defects consti-
tuted the 2 comparison groups in the birth cohort. Children
with birth defects were identiﬁed through the Texas Birth
Defects Registry, an active surveillance system. Registry staff
routinely visit all delivery and pediatric hospitals in Texas, as
well as birth centers and midwife facilities. A case is deﬁned
as an infant/fetus with any major structural or chromosomal
anomaly, whose mother is resident in the Registry coverage
area at the time of delivery (based on the birth certiﬁcate or,
if absent, the medical record). The Texas Birth Defects Reg-
istry includes all cases of structural or chromosomal birth
defects that are diagnosed by a physician and recorded in
medical records. However, the Registry is limited by the
sometimes short descriptions found there. Diagnoses with
qualiﬁers such as ‘‘suggests’’ or ‘‘rule out’’ are typically
excluded from statistical analyses and studies. Birth de-
fects associated with prematurity (e.g., patent ductus arte-
riosus) are not abstracted if a child is born preterm.
Defects that are not likely to have a signiﬁcant impact
on the child’s life, health, or functioning are recorded only
if they co-occur with one that is. Information is abstracted
from medical records into a Web-based system where it un-
dergoes extensive quality checks. That includes review by
clinical geneticists of roughly 60% of the Registry records
(selected on the basis of criteria to ﬁnd the cases most likely
to be problematic).
The Texas Birth Defects Registry started in South Texas
and the Houston/Galveston area and gradually expanded so
that, byJanuary1999, itcoveredthe entirestate.Birthdefects
are coded by using a 6-digit system (sometimes referred to as
‘‘BPA codes’’) based on the 1979 British Paediatric Asso-
ciation Classiﬁcation of Diseases and the World Health Or-
ganization’s 1979 International Classiﬁcation of Diseases,
Ninth Revision, Clinical Modiﬁcation, as modiﬁed by the
US Centers for Disease Control and Prevention (CDC) and
the Texas Department of State Health Services. Each birth
defect is assigned diagnostic certainty; roughly 96.7% are
deﬁnite and 3.3% are possible/probable. All pregnancy out-
comes are included (livebirths, spontaneous fetal deaths, and
pregnancy terminations). Registry cases are linked with birth
certiﬁcate data ﬁrst by deterministic matching (based on
exact matches) by a variety of combinations of individual
identiﬁers (date of birth, names, and so on). Cases that are
not matched are then subjected to human clerical review for
further matching. Over 96.2% of Texas Birth Defects Reg-
istry cases are linked to a birth certiﬁcate by use of this
approach.
In the present study, 115,686 liveborn children were iden-
tiﬁed by the Texas Birth Defects Registry as having one or
more deﬁnitely diagnosed birth defects and constituted the
birth defects comparison group. Individual birth defects
were grouped into categories routinely presented by the
Registry in their annual reports and to the CDC. Those live-
born children not registered with the Texas Birth Defects
Registry as having either a deﬁnite or possible/probable
birth defect constituted the non-birth defects comparison
group in the cohort. All children in this study had a birth
certiﬁcate.
Children diagnosed with cancer before age 15 years
were identiﬁed through linkage of birth certiﬁcate data with
the database of the Texas Cancer Registry, a statewide
population-based registry that collects data on incident cases
of cancer occurring among Texas residents. The Texas Can-
cer Registry meets high-quality data standards set by the
CDC and is ‘‘Gold-Certiﬁed’’ by the North American
Association of Central Cancer Registries. The Texas Cancer
Registry data included cancer diagnoses made between 1996
and 2005 (the latest data year available at the time of the
study). Cancer cases were coded according to the Inter-
national Classiﬁcation of Childhood Cancer, Third Edition
(ICCC-3), which categorizes childhood cancers into 12 major
groups (14).
The linkage between the Texas Cancer Registry and birth
certiﬁcate data was conducted by using Link Plus, version
2.0, software developed by the CDC (Atlanta, Georgia). The
software matches records using both deterministic and
probabilistic methods. The linkage included all records
that matched exactly by the infant’s ﬁrst name, last name,
date of birth, and sex. In addition, records that did not match
exactly because of data entry errors, missing data, or use of
alternate names were identiﬁed throughprobabilistic methods,
which weighted and scored the likelihood of a match based
on the information that did correspond. Possible matches
were manually reviewed and included address ﬁelds from
the birth certiﬁcate and Texas Cancer Registry data to help
determine true matches.
Data on potential confounders of birth defect-childhood
cancer associations were captured from the birth certiﬁcate
data ﬁle. Each subject contributed person-years of observa-
tion from the time of birth to either diagnosis with cancer or
December 31, 2005, whichevercame ﬁrst. Records for study
subjects with multiple birth defects were consolidated when
total birth defects were the unit of analysis; each individual
defect contributed to the person-time for the analyses eval-
uating speciﬁc defects or groups of defects. The associations
between the child’s baseline characteristics and birth defects
status and the diagnosis of cancers before age 15 years were
estimated by using incidence rate ratios and their corre-
sponding 95% conﬁdence intervals. The child’s gender, birth
weight, plurality, and birth order, as well as the mother’s age,
race/ethnicity, and education, were all evaluated as potential
confounders through Cox proportional hazards regression
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 analyses (15) and showed no effect (i.e., less than 10%
change in point estimates) on the main analysis of birth
defects and childhood cancers, so only unadjusted incidence
rate ratios are presented.
RESULTS
A total of 115,686 children in the birth cohort of 3,186,911
(3.6%) were identiﬁed as having one or more birth defects.
The distribution of maternal race/ethnicity and educational
attainment was similar among children with and without
birth defects, but slightly more mothers of children with birth
defects were aged 35 years or older at the time of the child’s
birth (Table 1). Slightly more males were born with birth
defects than females. As indicated by both birth weight and
gestational age, children with birth defects were smaller at
birth than children without birth defects, and more multiple
births occurred among children with birth defects.
A total of 2,351 cancer cases were identiﬁed in this birth
cohort; 239 cases had one or more birth defects (Table 2).
Children with any birth defect had a 3-fold increased risk of
developing a childhood cancer when compared with children
without birth defects (incidence rate ratio (IRR) ¼ 3.05, 95%
conﬁdence interval (CI): 2.65, 3.50) (Table 3). Every major
ICCC-3 cancergroup had at least 1 child who also had a birth
defect, and there were statistically signiﬁcant elevated risk
ratios for leukemia (IRR ¼ 1.39, 95% CI: 1.09, 1.75), ret-
inoblastoma (IRR ¼ 2.34, 95% CI: 1.21, 4.16), soft-tissue
sarcomas (IRR ¼ 2.12, 95% CI: 1.09, 3.79), and germ cell
tumors (IRR ¼ 5.19, 95% CI: 2.67, 9.41). By age, the asso-
ciation between any birth defect and total childhood cancers
was more pronounced among children diagnosed with can-
cer before age 1 year (IRR ¼ 1.53, 95% CI: 1.23, 1.89) (data
not shown). The most common cancers in these youngest
children were leukemias, but cancers from every major
ICCC-3 group were reported (data not shown).
When the risk of any childhood cancer by speciﬁc birth
defects grouping was considered, risk ratios for total child-
hood cancers were elevated for every birth defects group
except musculoskeletal defects, with most achieving statisti-
cal signiﬁcance and incidence rate ratios ranging from ap-
proximately 2-fold to over 15-fold (Table 4). The strongest
association was seen for chromosomal defects (IRR ¼
15.52, 95% CI: 11.66, 20.27), which reﬂected leukemia
incidence among Down syndrome children (51 of 55 trisomy
cancer cases were Down syndrome children with leukemia
diagnoses).
Leukemia consistently accounted for the highest percent-
age of cancers among the different birth defects groups
examined (Table 5). Cardiac and circulatory defects were
the most frequent type of birth defects to also have a cancer
diagnosis, and 50% of these children were diagnosed with
leukemia (76/153). Although there were only 5 children
with respiratory defects who developed cancer, 4 of the 5
were diagnosed with leukemia. After leukemia, central ner-
vous system neoplasms and neuroblastoma were the next
most common cancers diagnosed among children with birth
defects. For most birth defects, however, there was an array
of cancer types reported among the cases.
DISCUSSION
This analysis indicates that children with birth defects are
at increased risk of developing some form of cancer when
compared with children without birth defects. Leukemias,
retinoblastomas, soft-tissue sarcomas, and germ cell tumors
appear to be the cancers this population is most at risk of
developing, and children with birth defects who are under
the age of 1year showed a higherrisk ofdeveloping a cancer
than older children. With the exception of musculoskeletal/
reduction defects, every category of birth defect evaluated
was associated with cancer development in this population,
with most categories showing between 2-fold and 4-fold
increased risk when compared with children without birth
defects.
Earlier studies have consistently found an increased risk
of cancer development in children with birth defects (1–7),
and all have conﬁrmed, as this study did, a very strong asso-
ciation between Down syndrome and childhood leukemias.
Working from the hypothesis that the chromosomal defect
in Down syndrome children is a necessary but not sufﬁcient
causal factor for leukemia in these children, a series of
studies from the Children’s Oncology Group have investi-
gated whether environmental exposures that have shown
some association with leukemia in non-Down syndrome
children might have a similar or more pronounced role in
the Down syndrome population. These studies did not conﬁrm
an association with medical test irradiation (16), maternal
health conditions during pregnancy (17), most reproductive
history factors and infertility treatment (12), or other con-
genital abnormalities (18), but they did ﬁnd that some
household chemical exposures may play a role (11). There
is also some evidence from this study population of a pro-
tective effect with maternal vitamin use (10) and infections
in early life (19). To investigate the inﬂuence of chromo-
somal defects on the overall study results, we excluded sub-
jects with any chromosomal defect from the analyses, which
resulted in a lowered incidence rate ratio for leukemia as
w e l la sf o rt o t a lc a n c e r s .F o ra l lo t h e rc a n c e rc a t e g o r i e s ,
however, the point estimateseitherincreased(neuroblastoma,
retinoblastoma, hepatic tumors) or were unchanged, and
estimates were less precise. The overall pattern of results
was similar to that based on the models that included these
children (data not shown). In addition to children with chro-
mosomal defects, there was an overall increased risk of
leukemia among children with birth defects. Among children
with cardiac and circulatory defects, the group which had
the most total cancer diagnoses, there was also some indica-
tion that leukemia was the most common cancer type.
Most, but not all (3, 4), epidemiologic studies of birth
defects and childhood cancers have reported some evidence
of increased risk of retinoblastoma, with the magnitude of
risk ranging from a 2-fold to a 15-fold increase (1, 2, 5–7).
As with the results presented here, these studies generally
found that, rather than a concentration of a speciﬁc class of
birth defect, various types of birth defects were found among
the retinoblastoma cases.
Studies have generally reported a non-statistically signif-
icant increased risk of soft-tissue sarcomas with magnitudes
similar to the 2-fold risk seen in this study (3, 5, 6). Rankin
Birth Defects and Childhood Cancer Risk 1219

































































































No. % No. % No. %
Maternal age at child’s birth, years
 20 16,597 14.4 453,462 14.77 470,059 14.8
21–24 30,704 26.5 869,348 28.31 900,052 28.3
25–29 29,832 25.8 820,618 26.72 850,450 26.7
30–34 23,317 20.2 608,401 19.81 631,718 19.8
35–39 12,079 10.4 265,574 8.65 277,653 8.7
 40 3,152 2.7 53,415 1.74 56,567 1.8
Total 115,681 100.0 3,070,818 100 3,186,499 100.0
Maternal race/ethnicity
White non-Hispanic 46,297 40.1 1,146,335 37.38 1,192,632 37.5
Black non-Hispanic 12,144 10.5 334,690 10.91 346,834 10.9
Hispanic 53,731 46.5 1,480,474 48.27 1,534,205 48.2
Other non-Hispanic 3,348 2.9 105,567 3.44 108,915 3.4
Total 115,520 100.0 3,067,066 100 3,182,586 100.0
Maternal educational attainment
Less than high school 36,571 32.1 999,935 33.02 1,036,506 33.0
High school 34,664 30.4 924,558 30.53 959,222 30.5
More than high school 42,627 37.4 1,103,541 36.44 1,146,168 36.5
Total 113,862 100.0 3,028,034 100 3,141,896 100.0
Child’s sex
Male 68,268 59.0 1,560,583 50.81 1,628,851 51.1
Female 47,419 41.0 1,510,652 49.19 1,558,071 48.9
Total 115,687 100.0 3,071,235 100 3,186,922 100.0
Birth weight, g
<1,500 7,725 6.7 34,937 1.14 42,662 1.3
1,500–1,999 5,858 5.1 42,153 1.37 48,011 1.5
2,000–2,499 10,380 9.0 142,919 4.66 153,299 4.8
 2,500 91,560 79.3 2,849,110 92.83 2,940,670 92.3
Total 115,523 100.0 3,069,119 100 3,184,642 100.0
Gestational age, weeks
<32 8,041 7.1 43,309 1.43 51,350 1.6
32–36 18,108 15.9 249,243 8.22 267,351 8.5
 37 87,596 77.0 2,737,893 90.35 2,825,489 89.9
Total 113,745 100.0 3,030,445 100 3,144,190 100.0
Plurality
Singleton 109,809 94.9 2,988,224 97.3 3,098,033 97.2
Multiple 5,869 5.1 82,777 2.7 88,646 2.8
Total 115,678 100.0 3,071,001 100 3,186,679 100.0
Birth order
First 80,333 71.8 2,099,915 70.76 2,180,248 70.8
Second 18,872 16.9 530,656 17.88 549,528 17.9
Third 7,646 6.8 210,486 7.09 218,132 7.1
Fourth 2,946 2.6 75,965 2.56 78,911 2.6
Fifth or higher 2,043 1.8 50,431 1.7 52,474 1.7
Total 111,840 100.0 2,967,453 100 3,079,293 100.0
Carozza et al. 1220


























































































 et al. (7) found an increased risk of 2.98 for rhabdomyo-
sarcoma speciﬁcally, but this increase was not statistically
signiﬁcant.
In a study from the Children’s Oncology Group, Johnson
et al. (20) reported a 2.5-fold increased risk of germ cell
tumors for males with any congenital abnormality, with risk
increasing for children with multiple abnormalities. The
association found in this study was essentially due to crypt-
orchidism (undescended testicle). This population also had
increased risk of extragonadal germ cell tumors associated
with mental retardation, congenital heart defects, and skeletal
defects. Other studies have also reported associations be-
tween skeletal and congenital heart defects and germ cell
tumors (4, 6).
The differences in study results may be due to variations
in inclusion criteria for birth defects or in case ascertainment
(both for birth defects and childhood cancers). One of the
strengths of this study is that the data were derived from
high-quality, population-based registries for both birth de-
fects and cancers. In addition, this study had a relatively
large number of childhood cancer cases available for analy-
sis. Small numbers in previous studies may also be an expla-
nation for inconsistencies in point estimates for speciﬁc birth
defects and cancer types. Most studies had approximately
55 or fewer total cancers among their birth defects children
(1–3, 5, 7), severely restricting their ability to investigate the
relations among the less common cancers and birth defects.
One study limitation to note is the lack of death certiﬁcate
linkage in the study cohort to allow for adjustment of person-
year contributions for children who had died before the study
end date. Additionally, the maximum amount of follow-up
time was 10 years, so cancers that develop more commonly
in late childhood, such as thyroid and bone cancers, would
beunderrepresentedinthesedata.Also,someminorstructural
birth defects, particularly septal defects, may go undiag-
nosed in otherwise healthy children but may be more likely
to be diagnosed in children with serious illnesses like cancer.
This study did not include review of individual birth defects
records by a clinical geneticist or dysmorphologist to allow
for exclusion of birth defects diagnoses, such as minor septal
defects, which were identiﬁed as a consequence of a cancer
diagnosis. Because diagnoses of birth defects are accepted by
the Texas Birth Defects Registry only up to the ﬁrst birthday
of the child, however, we were able to evaluate the potential
impact of septal defects that may have been diagnosed
solely as a result of cancer diagnosis by excluding cases
whose cancer was diagnosed before age 1 year. Point estimates
Table 2. Distribution of Birth Defect Cases by ICCC-3 Cancer Groups Among Texas Children Born During
1996–2005
ICCC-3 Group
With Birth Defect Without Birth Defect Total
No. % No. % No. %
Leukemias 84 35.2 742 35.1 826 35.1
Lymphomas 8 3.4 137 6.5 145 6.2
Central nervous system 35 14.6 394 18.7 429 18.3
Neuroblastoma 31 13.0 274 13.0 305 13.0
Retinoblastoma 13 5.4 125 5.9 138 5.9
Renal tumors 14 5.9 172 8.1 186 7.9
Hepatic tumors 16 6.7 45 2.1 61 2.6
Malignant bone tumors 1 0.4 19 0.9 20 0.9
Soft tissue sarcomas 15 6.3 102 4.8 117 5.0
Germ cell tumors 17 7.1 60 2.8 77 3.3
Other epithelial 2 0.8 19 0.9 21 0.9
Other and unspeciﬁed 1 0.4 11 0.5 12 0.5
Total 239 2,112 2,351
Abbreviation: ICCC-3, International Classiﬁcation of Childhood Cancer, Third Edition.
Table 3. Risk Ratios by ICCC-3 Cancer Group for Any Birth Defect
Versus No Birth Defect Among Texas Children Born During
1996–2005
ICCC3 Cancer Group IRR 95% CI
Leukemias 1.39 1.09, 1.75
Lymphomas 1.80 0.76, 3.64
Central nervous system 1.11 0.76, 1.57
Neuroblastoma 1.43 0.94, 2.10
Retinoblastoma 2.34 1.21, 4.16
Renal tumors 1.11 0.59, 1.91
Hepatic tumors 1.00 0.52, 1.83
Malignant bone tumors 0.63 0.02, 3.99
Soft tissue sarcomas 2.12 1.09, 3.79
Germ cell tumors 5.19 2.67, 9.41
Other epithelial 2.98 0.34, 12.34
Other and unspeciﬁed 5.05 0.12, 34.75
Total cancers 3.05 2.65, 3.50
Abbreviations: CI, conﬁdence interval; ICCC-3, International Clas-
siﬁcationof Childhood Cancer, ThirdEdition; IRR, incidencerate ratio.
Birth Defects and Childhood Cancer Risk 1221


























































































 were slightly lower and less precise, but the overall pattern
of results was similar to that based on the models that in-
cluded these children (data not shown). Another limitation is
that the analyses in this paper did not stratify infants with
isolated versus multiple defects. Such analyses can be rele-
vant, because the cases with a birth defect with or without
co-occurring defects may be different etiologically (21, 22).
Because of this, we intend to address this in future analyses
with more cases of birth defects to allow stratiﬁcation with
sufﬁcient statistical power.
There are several ways to consider the underlying mech-
anisms atworkinthecomplexrelationsbetweenbirthdefects
and childhood cancers. As Mili et al. (2) noted, it is possible
that 1) a birth defect can act to increase the risk of childhood
cancers; 2) a cancer can predispose a child to developing
a birth defect; and/or 3) birth defects and cancers occur con-
currently through some set of common underlying factors.
The patterns seen in the results of this study engender several
questions. For example, the analysis revealed a wide range of
birth defects related to a wide range of cancers. Narod et al.
(4) speculated that this may indicate mutations in developmen-
tal genes early in embryogenesis leading to tissue mosaicism,































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4. Risk of Any Childhood Cancer for Birth Defect Groups and








Central nervous system 17 3.61 2.10, 5.79
Neural tube 4 3.03 0.83, 7.78
Eye and ear 6 3.47 1.27, 7.56
Anophthalmia/
microphthalmia
5 6.91 2.24, 16.14
Cardiac and circulatory 91 3.50 2.81, 4.31
Conotruncal 7 3.14 1.26, 6.47
Septal 60 3.05 2.32, 3.94
Left ventricular outﬂow
tract
54 4.22 3.16, 5.53
Respiratory 5 3.58 1.16, 8.36
Oral clefts 11 2.69 1.34, 4.82
Gastrointestinal 13 1.69 0.90, 2.89
Gastrointestinal
atresia/stenosis
5 2.56 0.83, 5.97
Genitourinary 34 2.37 1.64, 3.32
Musculoskeletal 5 0.88 0.29, 2.06
Limb reduction defects 1 0.80 0.02, 4.49
Abdominal wall defects 3 2.26 0.47, 6.62
Chromosomal
b 55 15.52 11.66, 20.27
Any monitored defect 234 2.86 2.49, 3.28
Abbreviations: CI, conﬁdence interval; IRR, incidence rate ratio.
a Duplicates within each defects group have been removed; that is,
a child is counted only once.
b This group includes trisomy 21 (Down syndrome), trisomy 13
(Patau syndrome), and trisomy 18 (Edwards syndrome).
Carozza et al. 1222


























































































 be predictive of cancer type or birth defect or both. Along
with others, this study also found that there was a higher
magnitude of risk for solid tum o r sa m o n gc h i l d r e nw i t h
birth defects than for leukemias or lymphomas, indicating
that perhaps these tumors are related to mutations expressed
early in development, in contrast to mutations later in devel-
opment when cells are forming blood and lymphatic constit-
uents (4). This is supported in part by studies showing that
developmental genes that have a role in body plan formation
during embryogenesis are also involved in cancer develop-
ment (e.g., Gorlin and Rubinstein-Taybi syndromes) (23).
Genetics ﬁgures prominently in the etiology of speciﬁc
birth defects, as well as speciﬁc childhood cancers. Studies
of cancer patterns in parents and siblings of individuals with
birth defects, however, do not point to a common inherited
genetic pattern that links birth defects and cancers (24, 25).
Instead, it may be that birth defects confer a genetic suscep-
tibility such that environmental exposures are less well tol-
erated in this high-risk population. As the studies in Down
syndrome children indicate, there is likely to be a role for
speciﬁc environmental toxins and dietary factors in the ini-
tiation and/or promotion of carcinogenesis in children with
birth defects. In considering these results within the Knudson
‘‘two hit hypothesis’’ for some childhood cancers (26), chil-
dren with birth defects may bedescribed as candidates already
having the ﬁrst genetic ‘‘hit’’ and, hence, may have increased
susceptibility to cancer from birth or earlier. If this is the case,
further study of the complex relation between these 2 rare
events may lead to not only a better understanding of the
etiology of both but also possible prevention strategies.
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